Abstract:Following the publication of this paper, it was drawn to the Editors' attention by a concerned reader that cell invasion assay data in the article (featured in Fig. 4A) were strikingly similar to data appearing in different form in another article by different authors at different research institutions, which had already been published elsewhere at the time of the present article's submission. Furthermore, flow cytometric data featured in Fig. 2D were strikingly similar to those in another previously published paper, and cell cyle data included in Fig. 3 had apparently previously published elsewhere. Owing to the fact that the contentious data in the above article had already appeared in different form in other articles prior to its submission to<em> Molecular Medicine Reports</em>, the Editor has decided that this paper should be retracted from the Journal. The authors also expressed their intention to retract the paper on the grounds that the corresponding author and several of the authors failed to confirm the approval of the final version of the manuscript. The Editor apologizes to the readership for any inconvenience caused. [the original article was published on <em>Molecular Medicine Reports</em> 13: 2301‑2307, 2016; DOI: 10.3892/mmr.2016.4799]

[Retracted] Knockdown of PREX2a inhibits the malignant phenotype of glioma cells

[Retracted] CXCL5 promotes the proliferation and migration of glioma cells in autocrine‑ and paracrine‑dependent manners

[Retracted] MicroRNA‑874 Inhibits Growth, Induces Apoptosis and Reverses Chemoresistance in Colorectal Cancer by Targeting X‑linked Inhibitor of Apoptosis Protein

[Retracted] AdipoR1‐mediated miR‐3908 inhibits glioblastoma tumorigenicity through downregulation of STAT2 associated with the AMPK/SIRT1 pathway

Retraction: Cxcl5 Promotes The Proliferation And Migration Of Glioma Cells In Autocrine- And Paracrine-Dependent Manners (Retraction Of Vol 36, Pg 3303, 2016)

[Retracted] SOX2 knockdown inhibits the migration and invasion of basal cell carcinoma cells by targeting the SRPK1‐mediated PI3K/AKT signaling pathway

[Retracted] IQGAP1‐siRNA inhibits proliferation and metastasis of U251 and U373 glioma cell lines

RETRACTED: Neferine Inhibits Proliferation, Migration and Invasion of U251 Glioma Cells by Down-Regulation of Mir-10B.

[Retracted] Silencing of RTKN2 by siRNA suppresses proliferation, and induces G1 arrest and apoptosis in human bladder cancer cells

[Retracted] Tripartite motif 16 suppresses breast cancer stem cell properties through regulation of Gli‐1 degradation via the ubiquitin‐proteasome pathway

[Retracted] Activation of the LKB1‐SIK1 signaling pathway inhibits the TGF‐β‐mediated epithelial‐mesenchymal transition and apoptosis resistance of ovarian carcinoma cells

[Retracted] SET and MYND domain‐containing protein 3 is overexpressed in human glioma and contributes to tumorigenicity

[Retracted] MicroRNA‑655 Attenuates the Malignant Biological Behaviours of Retinoblastoma Cells by Directly Targeting PAX6 and Suppressing the ERK and P38 MAPK Signalling Pathways

[Retracted] Propofol modulates the proliferation, invasion and migration of bladder cancer cells through the miR‐145‐5p/TOP2A axis

[Retracted] Silencing cyclin‑dependent kinase inhibitor 3 inhibits the migration of breast cancer cell lines

[Retracted] Glutathione peroxidase 2 overexpression promotes malignant progression and cisplatin resistance of KRAS‐mutated lung cancer cells

[Retracted] microRNA‑188 acts as a tumour suppressor in glioma by directly targeting the IGF2BP2 gene

[Retracted] Mammalian STE20‑like kinase 1 regulates pancreatic cancer cell survival and migration through Mfn2‑mediated mitophagy

[Retracted] Effects of Grb2‐associated binding protein 2‐specific siRNA on the migration and invasion of MG‐63 osteosarcoma cells

[Retracted] Schisandrin B inhibits epithelial‐mesenchymal transition and stemness of large‐cell lung cancer cells and tumorigenesis in xenografts via inhibiting the NF‐κB and p38 MAPK signaling pathways

[Retracted] hsa‐miR‐212 modulates the radiosensitivity of glioma cells by targeting BRCA1